3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Breast Neoplasms
15
Leukemia
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myeloid, Chronic-Phase
10
Recurrence
8
Prostatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Neoplasm Metastasis
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Melanoma
5
Burkitt Lymphoma
5
Pancreatic Neoplasms
4
Leukemia, Myeloid, Acute
4
Glioblastoma
4
Blast Crisis
4
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Neoplasms
3
Lymphoma
3
Gliosarcoma
3
Sarcoma
2
Salivary Gland Neoplasms
2
Rhabdomyosarcoma
2
Rectal Neoplasms
2
Polycythemia Vera
2
Oligodendroglioma
2
Multiple Myeloma
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
ofatumumab
10
Cyclophosphamide
6
fludarabine
5
ibrutinib
4
fludarabine phosphate
4
Bortezomib
3
Tablets
2
Chlorambucil
2
tirabrutinib
1
pegaspargase
1
nelarabine
1
immunotoxin HA22
1
bempegaldesleukin
1
Whole-Body Irradiation
1
Vincristine
1
Panobinostat
1
Observation
1
Nivolumab
1
Mitoxantrone
1
Methotrexate
1
Mesna
1
Mercaptopurine
1
Magnetic Resonance Imaging
1
MLN 8237
1
Lenalidomide
1
KW-2478
1
Hsp90 inhibitor KU757
1
Etoposide
1
Electrocardiography
1
Echocardiography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, B-Cell
×
Dasatinib
×
Clear all
No trials found.